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Abstract
DNA has been used as a material for the construction of
nanoscale objects. These nanostructures are programmable
and allow the conjugation of biomolecular guests to
improve their functionality. DNA nanostructures display a
wide variety of characteristics, such as cellular permeabil‐
ity, biocompatibility and stability, and responsiveness to
external stimuli, making them excellent candidates for
applications in nanomedicine.
Keywords DNA Nanostructures, DNA Origami, Nanome‐
dicine, DNA Nanodevices
1. Introduction
The impact of nanotechnology in the field of medicine has
been profound in the past two decades, with new nanoscale
materials, such as nanofibres [1], liposomes [2] and nano‐
particles [3], having been developed for use in a variety of
biomedical applications. DNA is one such material that has
found an exemplary use within nanomedicine. Apart from
its well-known role as a genetic material, DNA has been
shown to be valuable as a molecular building block for the
construction of nanoscale objects [4]. With its diameter of
~2 nm and a helical pitch of ~3.4-3.6 nm, DNA is inherently
a nanoscale material. Moreover, the highly specific Wat‐
son-Crick base pairing (A:T and G:C) provides a molecular
recognition system for designing complex structures using
DNA [5]. In addition, sticky end cohesion [6] provides
control over the programmable assembly of hierarchical
structures based on DNA motifs [7]. While DNA motifs can
be used to construct smaller objects, the DNA origami
technique [8] has been used to create custom-made DNA
nanostructures that are hundreds of nanometres in size.
These features of DNA have made it useful in the construc‐
tion of a variety of materials, such as two- [9] and three-
dimensional lattices [10-13], topologically linked arrays
[14-15], nanomachines [16-18] and biosensors [19-20].
These novel DNA materials have been used in a variety of
biomedical applications [21], which include the triggered
release of cargo, biosensing, synthetic vaccines, drug
delivery and in vivo imaging (Figure 1).
2. Applications in Immunostimulation and Drug
Delivery
DNA nanostructures exhibit several characteristics that
make them promising candidates for applications in
nanomedicine. One such aspect is enhanced cellular
permeability [22], compared to single-stranded and
double-stranded DNA. This feature allows DNA architec‐
tures, modified with biologically active molecules, to
trigger cellular mechanisms. For example, DNA origami
nanostructures containing CpG sequences on their surface
were shown to induce a high level of immune response in
mammalian cells (Figure 2a) [23]. The DNA nanostructure
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used in this case was a 30-helix nanotube constructed from
an 8634-nucleotide single-stranded DNA scaffold and over
200 staple strands. Some of the staple strands were modi‐
fied in order to provide extensions that can attach up to 62
CpG sequences. Endosomal uptake of these structures was
shown by fluorescence microscopy, and CpG-loaded DNA
nanotubes exhibited significantly higher cell permeability.
Moreover, these constructs elicited a higher immune
response in mouse splenocytes by triggering an immunos‐
timulatory cascade, which was mediated by Toll-like
receptor 9 (TLR9). The stability and internalization of these
nanotubes show that DNA-based nanostructures are
promising delivery vehicles for immune system activation.
Such features can also be combined with the functionaliza‐
Figure 1. Gallery of DNA nanostructures used for biomedical applications.
Illustrations of synthetic vaccine complexes [24], a DNA origami box that
responds to external stimuli [31], DNA nanotube/CpG sequences for
immunostimulation [23], DNA origami-gold nanorod complexes for cancer
therapy [29], DNA origami nanopliers for pH sensing [38], DNA nano‐
switches for nucleic acid detection [20], a DNA nanorobot for molecular
payloads [32] and a DNA icosahedron for in vivo imaging [36].
tion of proteins in order to create antigen-adjuvant com‐
plexes. Streptavidin molecules have been functionalized
onto tetrahedral DNA nanostructures, along with CpG
oligo-deoxynucleotides, for the creation of a synthetic
vaccine complex (Figure 2b) [24]. The fully assembled
vaccine complex exhibited a higher level of immunogenic‐
ity when compared to either an unassembled mixture of
streptavidin and CpG sequences or streptavidin alone.
Such DNA scaffolds are useful in constructing antigen-
adjuvant complexes that elicit a strong and specific anti‐
body response in vivo, without inducing an undesirable
response against the carrier itself. Other examples of DNA
architectures that have been used for immunostimulation
include a DNA tetrahedron with CpG motifs [25] and
polypod-like structures [26].
The stability of DNA nanostructures in cell lysates from
cancerous cell lines [27] has prompted research on the use
of these structures for cancer diagnosis and treatment. In
one such example, DNA origami structures in the shapes
of a triangle, square and tube, were used as carriers of the
anticancer drug doxorubicin [28]. The accumulation
capacity of different DNA origami shapes in tumour cells
was evaluated by tagging the structures with quantum dots
and using fluorescence imaging, in which the accumulation
level of triangle nanostructures was found to be optimal.
Doxorubicin was loaded onto the DNA origami structures
by incubating them for 24 hours, with about 50% of the drug
estimated to have been loaded onto the nanostructures.
These doxorubicin-loaded DNA origami structures
exhibited efficient cellular uptake, enhanced tumour
selectivity and long-lasting therapeutic effects. Specifically,
doxorubicin-loaded origami structures exhibited reduced
tumour burden in nude mice, compared to doxorubicin by
Figure 2. Drug delivery and cancer therapy using DNA nanostructures. (a) DNA origami nanotubes coated with CpG oligonucleotides for immunostimulation.
Adapted with permission from [23]. Copyright 2011, American Chemical Society (ACS). (b) DNA tetrahedra with streptavidin/CpG oligonucleotides forming
a synthetic vaccine complex Adapted with permission from [24]. Copyright 2012, ACS. (c) DNA origami/gold nanorod (GNR) complex for cancer treatment
using photothermal ablation Adapted with permission from [29]. Copyright 2015, Wiley-VCH.
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itself. In addition, gold nanorods functionalized on DNA
origami triangles and nanotubes have been used for
photothermal cancer therapy in vitro and in vivo (Figure
2c) [29]. Doxorubicin-loaded DNA origami structures have
also been shown to cause high cytotoxicity in human breast
adenocarcinoma cancer cells (MCF 7) [30].
Another feature of DNA-based nanostructures is that they
allow the encapsulation and release of drugs in a controlled
fashion, thus opening up new avenues in targeted drug
delivery. For example, dynamic DNA nanostructures, such
as the DNA origami box [31], can be locked or opened using
additional DNA strands and provide a route to the trig‐
gered delivery of cargo (Figure 3a). In this design, DNA
origami was used to create a six-connected planar struc‐
ture, which can then fold into the six faces of a cube-like
box. The segment on the top, which acts as a lid, was
"locked" by the formation of a duplex between the two
adjacent segments. One of the strands of this locking
duplex contained a single-stranded extension that can act
as a toehold. On the addition of a fully complementary
"key" DNA strand, the lid is opened via strand displace‐
ment of the lock strand. Moreover, DNA origami nano‐
structures have been used to host cargo molecules for
delivery to cells. One such example is a DNA origami
nanorobot containing two aptamers, which are specific to
two different receptors on the cell membrane (Figure 3b)
[32]. This structure is closed by hybridization of the
aptamer to a complementary strand, but is opened in the
presence of an antigen key (which can bind to the aptamer).
This nanorobot was programmed to deliver gold nanopar‐
ticles or antibody fragments in response to specific cell
receptors. Other examples of DNA nanostructures with the
ability to respond to external stimuli are a pH-dependent
DNA tetrahedron [33] and a temperature-triggered
octahedral DNA cage that can release enzymes [34].
3. Applications in Imaging and Biosensing
DNA nanostructures facilitate the attachment of a multi‐
tude of components, including fluorophores, making them
useful for imaging purposes. Tubular DNA origami with a
label-free fluorescent probe (carbazole-based biscyanine
molecule) has been used for the direct visualization of their
distribution and stability in live, cellular systems [35]. This
strategy allowed the monitoring of DNase I digestion of
origami nanostructures and the tracking of their localiza‐
tion in lysosomes. DNA polyhedra, encapsulating a
fluorescent biopolymer fluorescein isothiocyanate-dextran
(FD), have also been used for in vivo imaging (Figure 4a)
[36]. In this case, five-arm DNA branched junctions were
used to create the top and bottom halves of the DNA
icosahedron. FD was loaded into the DNA icosahedra and
tested in coelomocytes of Caenorhabditis elegans. These cells
express anionic ligand-binding receptors (ALBR), which
internalize negatively charged entities by receptor-mediat‐
ed endocytosis [37], thereby engulfing higher quantities of
FD encapsulated in the DNA icosahedron than FD by itself.
Furthermore, the functionality of this host-cargo complex
was demonstrated in vivo by quantitatively mapping pH
changes associated with endosomal maturation. Such
programmable host-cargo complexes can be used as
functional probes to interrogate biological phenomena,
both in living cells and whole organisms.
One other biological application of DNA nanostructures is
in chemical and biological sensing [19]. DNA-based
biosensors have proven to be cost-effective, sensitive and
have the potential to be used as point-of-care diagnostic
tools. For example, DNA-based nanoswitches have been
used for nucleic acid detection using an easy gel readout
[20]. The nanoswitch was designed from an M13 single
strand and complementary 'backbone' oligonucleotides.
Two of these strands can be modified to contain single-
stranded extensions, which are partly complementary to
the target sequence to be detected. The 'off' state of the
Figure 3. Stimuli responsive DNA nanostructures. (a) A DNA origami box
with a controllable lid that can be opened using additional DNA strands.
Reproduced with permission from [31]. Copyright 2009, Nature Publishing
Group (NPG). Single-particle reconstruction of the DNA box using cryo-EM
images is shown at the bottom. (b) A DNA nanorobot that can be triggered
open by antigen keys. Reproduced with permission from [32]. Copyright
2012, The American Association for the Advancement of Science. The
nanorobot has been used to deliver gold nanoparticles and antibody
fragments. TEM images of robots in closed and open conformations are
shown on the right. Scale bars: 20 nm.
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nanoswitch is a linear duplex, while target binding brings
the two detectors closer to form a looped 'on' state. The two
states of the nanoswitch migrate differently on a gel, thus
giving a binary read out. Another example is a DNA
origami-based nanoplier [38] used for pH sensing. The two
levers of the DNA origami nanoplier were designed to
contain a series of C-rich single-stranded extensions. The
device works on the basis of i-motif formation between C-
rich sequences at acidic pH. For example, the levers remain
in the "open" configuration at neutral pH; meanwhile, at
acidic pH, the C-rich strands form an intermolecular i-
motif, thereby bringing the two levers together into a
"closed" configuration. The two structural states can be
visualized using an AFM. Intracellular pH sensors have
also been developed based on the i-motif (Figure 4b) [17].
This nanomachine, called the "I-switch", consisted of a long
strand forming a duplex with two short strands. The two
Figure 4. DNA nanostructures for in vivo imaging and sensing applications.
(a) A DNA icosahedron containing fluorescein isothiocyanate-dextran (FD)
as a cargo used for in vivo imaging. Adapted with permission from [36].
Copyright 2011, NPG. Also displayed is an image showing internalization
of an icosahedron/FD complex in Drosophila haemocytes. Right: Endocytosis
pathways adopted by free and encapsulated FD (EE, early endosome; LE,
late endosome; Ly, lysosome; SV, spherical vesicle). (b) A nanomachine
based on a DNA i-motif for tracking pH changes in the endosomal furin
pathway. Adapted with permission from [17]. Copyright 2013, NPG.
Widefield images and corresponding donor-to-acceptor maps at different
pulse times are shown on the right.
ends of the long strand contained C-rich single-stranded
extensions containing a fluorescent dye. At neutral pH, the
three strands remain in the open linear structure (duplex)
and exhibit a low FRET signal due to the separation of the
two dyes. However, at acidic pH, the single-stranded
extensions fold to form an i-motif, thereby bringing the two
dyes into close proximity and resulting in a high FRET
signal. This system has been used to track real-time pH
changes in early endosomes and the trans-Golgi network.
4. Conclusion
In summary, DNA nanostructures portray a wide variety
of characteristics, such as cellular permeability, biocompat‐
ibility, site-specific functionalization of molecules and the
ability to respond to external stimuli, which in turn make
them excellent candidates for use in biomedical applica‐
tions [39-40]. A wide variety of structures in sizes ranging
from a few nanometres (based on DNA motifs) to hundreds
of nanometres and into the micrometre range (based on
DNA origami) can be created. Moreover, techniques such
as molecular canvas [41] and DNA bricks [42] provide
alternate routes to creating nanostructures. In addition,
micrometre scale arrays can be created by combining DNA
origami and lithography, which allows precise and
programmable surface interactions. Such assemblies
provide a large surface area for multiplexed diagnostic
purposes. Despite advantages, such as spatial positioning
of other biomolecules [43] through various conjugation
strategies [44], the use of DNA nanostructures also has
some limitations. For example, the DNA origami method
involves hundreds of staple strands, which is a limiting
factor; however, the cost of synthetic DNA used for these
purposes has reduced in recent times [45], making DNA a
viable material to use for biomedical applications. One
other issue is the dependence of the DNA origami techni‐
que on single-stranded scaffolds (the viral genome M13 is
frequently used), but the creation of custom-made DNA
origami scaffolds [46] allows the creation of structures of
various sizes in order fit their purpose. Applications in
nanomedicine will be aided by further research in the
encapsulation of a variety of drugs and biomolecules,
conjugation strategies and triggered responses based on
external and environmental stimuli. More intensive
research is needed for analysing the biocompatibility,
cellular uptake and intracellular behaviour of DNA
constructs, but they have so far exhibited unparalleled
advantages over current strategies for use in nanomedi‐
cine.
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